Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes.

White MR, Kandel R, Tripathi S, Condon D, Qi L, Taubenberger J, Hartshorn KL.

PLoS One. 2014 Jul 2;9(7):e101364. doi: 10.1371/journal.pone.0101364. eCollection 2014.

2.

Critical role of C-terminal residues of the Alzheimer's associated β-amyloid protein in mediating antiviral activity and modulating viral and bacterial interactions with neutrophils.

White MR, Kandel R, Hsieh IN, De Luna X, Hartshorn KL.

PLoS One. 2018 Mar 16;13(3):e0194001. doi: 10.1371/journal.pone.0194001. eCollection 2018.

3.

The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.

Tripathi S, Tecle T, Verma A, Crouch E, White M, Hartshorn KL.

J Gen Virol. 2013 Jan;94(Pt 1):40-9. doi: 10.1099/vir.0.045013-0. Epub 2012 Oct 10.

4.

Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.

Hillaire ML, Vogelzang-van Trierum SE, Kreijtz JH, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Gen Virol. 2013 Mar;94(Pt 3):583-92. doi: 10.1099/vir.0.048652-0. Epub 2012 Nov 14.

PMID:
23152369
5.

Collectins, H-ficolin and LL-37 reduce influence viral replication in human monocytes and modulate virus-induced cytokine production.

White MR, Tripathi S, Verma A, Kingma P, Takahashi K, Jensenius J, Thiel S, Wang G, Crouch EC, Hartshorn KL.

Innate Immun. 2017 Jan;23(1):77-88. doi: 10.1177/1753425916678470. Epub 2016 Nov 17.

PMID:
27856789
6.

Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.

Tripathi S, Wang G, White M, Qi L, Taubenberger J, Hartshorn KL.

PLoS One. 2015 Apr 24;10(4):e0124706. doi: 10.1371/journal.pone.0124706. eCollection 2015.

7.

Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.

Verma A, White M, Vathipadiekal V, Tripathi S, Mbianda J, Ieong M, Qi L, Taubenberger JK, Takahashi K, Jensenius JC, Thiel S, Hartshorn KL.

J Immunol. 2012 Sep 1;189(5):2478-87. doi: 10.4049/jimmunol.1103786. Epub 2012 Jul 30.

8.

Arginine-rich histones have strong antiviral activity for influenza A viruses.

Hoeksema M, Tripathi S, White M, Qi L, Taubenberger J, van Eijk M, Haagsman H, Hartshorn KL.

Innate Immun. 2015 Oct;21(7):736-45. doi: 10.1177/1753425915593794. Epub 2015 Jul 2.

9.

Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus.

Doss M, Ruchala P, Tecle T, Gantz D, Verma A, Hartshorn A, Crouch EC, Luong H, Micewicz ED, Lehrer RI, Hartshorn KL.

J Immunol. 2012 Mar 15;188(6):2759-68. doi: 10.4049/jimmunol.1101335. Epub 2012 Feb 15.

10.

Replication of swine and human influenza viruses in juvenile and layer turkey hens.

Ali A, Yassine H, Awe OO, Ibrahim M, Saif YM, Lee CW.

Vet Microbiol. 2013 Apr 12;163(1-2):71-8. doi: 10.1016/j.vetmic.2012.12.018. Epub 2012 Dec 22.

PMID:
23305617
11.
12.

The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.

Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K, Suzuki T, Komase K, Nobusawa E, Maenaka K, Kuroda M, Hasegawa H, Kawaoka Y, Tashiro M, Takeda M.

J Virol. 2014 May;88(10):5608-16. doi: 10.1128/JVI.03677-13. Epub 2014 Mar 5.

13.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

14.

Virus-neutralizing antibody response of mice to consecutive infection with human and avian influenza A viruses.

Janulíková J, Stropkovská A, Bobišová Z, Košík I, Mucha V, Kostolanský F, Varečková E.

Acta Virol. 2015 Jun;59(2):166-73.

PMID:
26104333
15.

Pulmonary surfactant protein D in first-line innate defence against influenza A virus infections.

Hillaire ML, Haagsman HP, Osterhaus AD, Rimmelzwaan GF, van Eijk M.

J Innate Immun. 2013;5(3):197-208. doi: 10.1159/000346374. Epub 2013 Feb 5. Review.

16.

Influenza A Virus Dysregulates Host Histone Deacetylase 1 That Inhibits Viral Infection in Lung Epithelial Cells.

Nagesh PT, Husain M.

J Virol. 2016 Apr 14;90(9):4614-4625. doi: 10.1128/JVI.00126-16. Print 2016 May.

17.

Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.

Nikolaidis NM, White MR, Allen K, Tripathi S, Qi L, McDonald B, Taubenberger J, Seaton BA, McCormack FX, Crouch EC, Hartshorn KL.

Am J Physiol Lung Cell Mol Physiol. 2014 Jun 1;306(11):L1036-44. doi: 10.1152/ajplung.00035.2014. Epub 2014 Apr 4.

18.

Phosphatidylglycerol suppresses influenza A virus infection.

Numata M, Kandasamy P, Nagashima Y, Posey J, Hartshorn K, Woodland D, Voelker DR.

Am J Respir Cell Mol Biol. 2012 Apr;46(4):479-87. doi: 10.1165/rcmb.2011-0194OC. Epub 2011 Nov 3.

19.

A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.

Hsu SF, Su WC, Jeng KS, Lai MM.

J Virol. 2015 Apr;89(7):3671-82. doi: 10.1128/JVI.03610-14. Epub 2015 Jan 14.

20.

The influenza A virus matrix protein as a marker to monitor initial virus internalisation.

Eierhoff T, Ludwig S, Ehrhardt C.

Biol Chem. 2009 May-Jun;390(5-6):509-15. doi: 10.1515/BC.2009.053.

PMID:
19335204

Supplemental Content

Support Center